MeSH term | MeSH ID | Detail |
---|---|---|
Lung Neoplasms | D008175 | 171 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
MeSH term | MeSH ID | Detail |
---|---|---|
Lung Neoplasms | D008175 | 171 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hur J et al. | Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | 2015 | Chem. Res. Toxicol. | pmid:25811541 |
Mora J et al. | Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). | 2015 | Clin Transl Oncol | pmid:25596034 |
Singh A et al. | Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells. | 2015 | J. Exp. Clin. Cancer Res. | pmid:26384788 |
Guzmán-Sánchez D and Asz-Sigall D | Alopecias due to drugs and other skin and systemic disorders. | 2015 | Curr. Probl. Dermatol. | pmid:26370648 |
Güler E et al. | An unknown side effect of isotretinoin: pericardial effusion with atrial tachycardia. | 2015 | Anatol J Cardiol | pmid:25625453 |
Karadag AS et al. | The effect of isotretinoin on retinol-binding protein 4, leptin, adiponectin and insulin resistance in acne vulgaris patients. | 2015 | Dermatology (Basel) | pmid:25573071 |
Iwamoto FM and Lassman AB | Factorial clinical trials: a new approach to phase II neuro-oncology studies. | 2015 | Neuro-oncology | pmid:25452393 |
Krishna S et al. | Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. | 2015 | JAMA Dermatol | pmid:25251777 |
Penas-Prado M et al. | Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. | 2015 | Neuro-oncology | pmid:25239666 |
Ratajewski M et al. | Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015 | Toxicol. Lett. | pmid:25455453 |